SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001546927-14-000166
Filing Date
2014-09-05
Accepted
2014-09-05 17:03:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 opaleye13gimprimisfiled.txt SC 13G 13622
  Complete submission text file 0001546927-14-000166.txt   15302
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83793 | Film No.: 141086573
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9B RUSSELL STREET CAMBRIDGE MA 02140
Business Address 9B RUSSELL STREET CAMBRIDGE MA 02140 617-997-9567
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

IRS No.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G